Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [14C]linezolid to healthy human subjects

Drug Metabolism and Disposition

Volumn 29, Issue 8, 2001, Pages 1136-1145

  Slatter, J G ^a   Stalker, D J ^a   Feenstra, K L ^a   Welshman, I R ^a   Bruss, J B ^a   Sams, J P ^a   Johnson, M G ^a   Sanders, P E ^a   Hauer, M J ^a   Fagerness, P E ^a   Stryd, R P ^a   Peng, G W ^a   Shobe, E M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; DRUG METABOLITE; LINEZOLID; MORPHOLINE DERIVATIVE; PNU 142300; PNU 142586; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG FECES LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RADIOACTIVITY; STEADY STATE;

ACETAMIDES; ADULT; ANTI-BACTERIAL AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FEMALE; FLUORINE RADIOISOTOPES; HALF-LIFE; HUMANS; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; MIDDLE AGED; OXAZOLIDINONES; SPECTROPHOTOMETRY, ULTRAVIOLET; WHOLE-BODY COUNTING;

EID: 0034932457     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Absorption distribution, metabolism and excretion of the oxazolidinone antibiotic linezolid (PNU-100766) in the Sprague Dawley Rat
2. A regulatory and industrial perspective of the use of carbon-14 and tritium isotopes in human ADME studies
3. The oxazolidinone linezolid inhibits translation initiation in bacteria
4. Biotransformation of moclobemide in humans
5. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with the binding of chloramphenicol and lincomycin
6. Directly-coupled HPLC-NMR spectroscopic studies of metabolism and futile deacetylation of phenacetin in the rat
7. U-100766 Safety, toleration and pharmacokinetics after oral and intravenous administration
8. Zyvox package insert
9. Mechanism of action of oxazolidinones: Effects of linezolid and eperezolid on translation reactions
10. Effect of age and sex on linezolid pharmacokinetics
11. Linezolid safety, tolerance, and pharmacokinetics following oral dosing twice daily for 14.5 days
12. Linezolid safety, tolerance, and pharmacokinetics after intravenous dosing twice daily for 7.5 days
13. High-performance liquid chromatographic analysis, plasma protein binding and red blood cell partitioning of phenprobamate
14. Oxazolidinone mechanism of action: Eperezolid inhibits the initiation event of protein synthesis in bacteria
15. Timolol metabolism in man and laboratory animals
16. In vitro metabolism of linezolid (PNU-100766): Lack of induction or inhibition of cytochrome P450 enzymes and studies on the mechanism of formation of the major human metabolite, PNU-142586
17. Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes
18. 14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in man